Skip to main content

Posts

Showing posts from June, 2016

4 New Elements - Half A Year Later

It has been just over 6 months since we had heard of the identification of 4 new elements in the periodic table. Just recently the elements have been given proposed names.  As a reminder, here's is some information about the four new elements which had their discovery confirmed in January of this year (2016) Element 113 – currently known by its placeholder name ununtrium – is the first to be discovered in east Asia. It was created by  Kosuke Morita ’s group at the RIKEN Nishina Center for Accelerator-based Science in Japan, by firing a beam of zinc-70 at a target made of bismuth-209. The group first claimed to have created the element in 2004, but there was still some uncertainty at that time because of the instability of one of its decay products. They followed up these experiments with  more convincing evidence in 2012 . Elements 115 (ununpentium) and 117 (ununseptium) were discovered by groups collaborating across three institutions – Lawrence Livermore National Labora

New medication “clears up” Psoriasis almost completely

Researchers at Northwestern University, USA, have succeeded in finding a drug that can clear psoriasis in the body, almost completely and   the great majority of the responses persist at least 60 weeks . The new drug called ixekizumab, tradename Taltz ® , is  a monoclonal antibody, prescribed to those with moderate to severe psoriasis. Research published in the prestigious journal, New England Journal of Medicine ; reports the results of 3 large, long-term clinical trials which saw 80% of patients psoriasis completely or almost completely cleared.  Psoriasis affects 3% of the world population. It is an immune-mediated inflammatory disease and its most significant symptom is itchy, dry and red skin. Accompanying those uncomfortable symptoms, psoriasis is also associated with an increased risk of depression, heart disease, and diabetes. What are Phase 3 trials? ( Understanding the Drug Discovery Process- Compound Interest ) "Usually 1000-3000 people, gauge